OpenAI Chief Executive Officer Sam Altman is visiting Washington to brief the Trump Administration and U.S. lawmakers on the next wave of artificial intelligence models. A key addition to his schedule is a meeting with Senator Mark Warner (D-Va.), the top Democrat on the Senate Intelligence Committee, as Congress ramps up efforts to shape rules for advanced AI. The discussions aim to establish a framework for reviewing AI systems, balancing innovation with national security concerns while addressing the implications of upcoming model capabilities for the workforce.

Legislative and Regulatory Push

Senator Warner, who also co-chairs the Senate Cybersecurity Caucus, recently backed legislation requiring certain advanced AI models to undergo safety testing before public release. This move aligns with broader congressional efforts to implement safeguards for increasingly powerful systems. OpenAI’s global public affairs chief, Chris Lehane, noted that if Congress fails to establish a national standard for AI governance, a "reverse federalism" approach may emerge. In this scenario, states would mirror each other’s rules and regulations surrounding AI.

OpenAI is currently supporting a proposal in Massachusetts that would require large AI companies to address potential severe AI-related risks. This state-level initiative is also supported by Anthropic, reflecting a coordinated industry stance in the absence of federal clarity.

Strategic Frameworks

The Trump administration is considering the creation of a standalone oversight body to evaluate AI systems. A proposal developed with input from Treasury Secretary Scott Bessent aims to provide AI companies with clearer expectations on model assessment. This approach mirrors a framework recently proposed by Google DeepMind CEO Demis Hassabis, who is also meeting with Washington offices to advocate for similar oversight measures.

Lehane emphasized the need for a unified approach to maintain U.S. technological leadership, cybersecurity defenses, and the ability to safely share AI models with allies. He highlighted that OpenAI’s new models will offer "interesting capabilities" particularly related to work and scaling operations.

Competitive Landscape

The urgency for a coordinated U.S. strategy follows the launch of the Kimi K3 model by Chinese AI startup Moonshot AI, which has challenged U.S. systems. Lehane pointed to China’s government-backed AI strategy as a benchmark for the effort required to compete globally. The briefing occurs against a backdrop of heightened regulatory actions, including Anthropic’s recent disabling of access to its flagship Fable 5 and Mythos 5 models after a U.S. government order to block foreign nationals from using the systems due to national security concerns.

Scott Winters has filed a lawsuit against OpenAI and CEO Sam Altman in San Francisco County Superior Court, alleging that ChatGPT’s advice to remain inactive directly contributed to a life-threatening pulmonary embolism. The case highlights growing legal risks for AI companies as chatbots increasingly serve as primary sources of health information for millions of users, with OpenAI reporting approximately 40 million daily health-related queries. Winters claims the AI model assessed his dizziness and groin tenderness with clinical confidence despite lacking medical qualifications, advising him to limit movement and stay home while dismissing the pain as unlikely to be dangerous.

The incident occurred in July 2025, when Winters was hospitalized the day after consulting the chatbot. According to the complaint, doctors linked his "massive pulmonary embolism" to the immobility recommended by the AI. Attorney Matthew Bergman stated that Winters nearly died because ChatGPT acted as a medical authority without assuming corresponding responsibility. The lawsuit seeks damages, the implementation of emergency guardrails, and an independent safety audit of ChatGPT Health, which OpenAI launched in January to help users interpret records and prepare for appointments.

Legal and Regulatory Context

The filing represents one of several recent legal challenges targeting OpenAI over safety concerns. It follows a separate Florida action alleging that ChatGPT endangered users and a May lawsuit claiming the platform’s advice contributed to a fatal overdose. These cases emerge as regulatory scrutiny intensifies around medical AI applications. A Nature Medicine study published in February this year found that AI did not help patients make better medical decisions than standard internet searches, raising questions about the efficacy and safety of relying on large language models for health guidance.

Company Response and Market Data

OpenAI maintains that its tools are designed to support, not replace, professional medical care. Spokesperson Drew Pusateri told CBS News that blaming chatbots alone oversimplifies medical decisions and could hinder access to useful tools. The company emphasizes that ChatGPT is not a doctor and should never be used as a substitute for diagnosis or treatment. Despite these disclaimers, market data indicates significant user reliance on AI for health queries. A West Health-Gallup survey found that 25% of U.S. adults had used AI for health information or advice, underscoring the widespread adoption that precedes this litigation.

What the Numbers Show

The disparity between user adoption and clinical validation presents a material risk for OpenAI. With 40 million daily health questions directed at ChatGPT, the potential for harm scales with usage volume. The following table outlines key metrics regarding AI health usage and safety concerns cited in the report:

The core conflict lies in the gap between the volume of interactions and the absence of proven clinical benefit. While OpenAI argues its tools aid in interpreting records, the Nature Medicine study suggests no improvement over traditional search methods. This divergence implies that as usage grows, so does the exposure to liability from incorrect or delayed diagnoses, particularly when users substitute professional care with AI-generated advice.